Lillie James Woodruff has filed 5 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 7730 shares of MapLight Therapeutics, Inc. ($MPLT) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 7730 | $0.00 | 298,862.0000 | 45,373,033 | 2.66% | 0.02% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 31395 | $0.00 | 31,395.0000 | 45,373,033 | 9999.99% | 0.07% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | F | Voting Common Stock | 45055 | $17.98 | 291,132.0000 | 45,373,033 | 13.40% | 0.10% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 32539 | $0.00 | 32,539.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 132023 | $0.00 | 132,023.0000 | 0 | 9999.99% | 0.00% |